BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28618997)

  • 1. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis.
    Shoshan-Barmatz V; Krelin Y; Chen Q
    Curr Med Chem; 2017; 24(40):4435-4446. PubMed ID: 28618997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
    Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V; Mizrachi D; Keinan N
    Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDAC1 functions in Ca
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
    Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
    J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
    Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
    Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
    Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
    J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative VDAC1 mutants reveal oligomeric VDAC1 to be the active unit in mitochondria-mediated apoptosis.
    Mader A; Abu-Hamad S; Arbel N; Gutiérrez-Aguilar M; Shoshan-Barmatz V
    Biochem J; 2010 Jul; 429(1):147-55. PubMed ID: 20420578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial VDAC, the Na
    Shoshan-Barmatz V; De S
    Adv Exp Med Biol; 2017; 981():323-347. PubMed ID: 29594867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mitochondrial Voltage-Dependent Anion Channel 1, Ca
    Shoshan-Barmatz V; De S; Meir A
    Front Oncol; 2017; 7():60. PubMed ID: 28443244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases.
    Shoshan-Barmatz V; Shteinfer-Kuzmine A; Verma A
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of VDAC1 Protects Against Glutamate-Induced Oxytosis and Mitochondrial Fragmentation in Hippocampal HT22 Cells.
    Nagakannan P; Islam MI; Karimi-Abdolrezaee S; Eftekharpour E
    Cell Mol Neurobiol; 2019 Jan; 39(1):73-85. PubMed ID: 30421242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/β-catenin signaling pathway.
    Yang X; Tang S; Dai C; Li D; Zhang S; Deng S; Zhou Y; Xiao X
    Food Chem Toxicol; 2017 Jul; 105():161-176. PubMed ID: 28343033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
    Abu-Hamad S; Arbel N; Calo D; Arzoine L; Israelson A; Keinan N; Ben-Romano R; Friedman O; Shoshan-Barmatz V
    J Cell Sci; 2009 Jun; 122(Pt 11):1906-16. PubMed ID: 19461077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
    Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
    Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.